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Abstract
Background:  The development of microarrays permits us to monitor transcriptomes on a
genome-wide scale. To validate microarray measurements, quantitative-real time-reverse
transcription PCR (Q-RT-PCR) is one of the most robust and commonly used approaches. The
new challenge in gene quantification analysis is how to explicitly incorporate statistical estimation
in such studies. In the realm of statistical analysis, the various available methods of the probe level
normalization for microarray analysis may result in distinctly different target selections and
variation in the scores for the correlation between microarray and Q-RT-PCR. Moreover, it
remains a major challenge to identify a proper internal control for Q-RT-PCR when confirming
microarray measurements.
Results: Sixty-six Affymetrix microarray slides using lung adenocarcinoma tissue RNAs were
analyzed by a statistical re-sampling method in order to detect genes with minimal variation in gene
expression. By this approach, we identified DDX5 as a novel internal control for Q-RT-PCR.
Twenty-three genes, which were differentially expressed between adjacent normal and tumor
samples, were selected and analyzed using 24 paired lung adenocarcinoma samples by Q-RT-PCR
using two internal controls, DDX5 and GAPDH. The percentage correlation between Q-RT-PCR
and microarray were 70% and 48% by using DDX5 and GAPDH as internal controls, respectively.
Conclusion: Together, these quantification strategies for Q-RT-PCR data processing procedure,
which focused on minimal variation, ought to significantly facilitate internal control evaluation and
selection for Q-RT-PCR when corroborating microarray data.
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Background
Microarrays, by making use of the sequence resources cre-
ated in genomic projects, are a powerful technology capa-
ble of measuring the expression levels of thousands of
genes simultaneously and have dramatically expedited
comprehensive understanding of gene expression profiles
for disease development. For example, microarray tech-
nology has been used to compare gene expression profiles
between normal and diseased cells and this has led to dra-
matic advances in the understanding of cellular processes
at the molecular level [1]. Several microarray platforms
are currently available. The short-oligonucleotide-based
Affymetrix GeneChip® arrays utilize multiple probes for
each gene with an automated control for the experimental
process from hybridization to quantification and thus
provide reliable and comparable data [2]. The multiple
probe sets for each gene are typically scattered across the
surface of the Affymetrix microarrays. Variations in inten-
sity from probe to probe or chip to chip for samples need
to be resolved to obtain a reliable level of expression. Var-
ious statistical algorithms are available for probe-cell level
normalization and expression-value summary.
Researchers are still confronted with challenging ques-
tions after completing the expression profiling and these
include how to validate and standardize the data process-
ing using proper statistical analysis. Quantitative-real
time-reverse transcription PCR (Q-RT-PCR) is widely used
and is a sensitive and robust technique for the detection
and quantification of often rare mRNA targets [3]. Q-RT-
PCR has also become one of the gold standards for both
pathogen detection and gene expression studies and is the
method of choice for corroborating microarray data [4].
In this study, the Q-RT-PCR system is based on the detec-
tion of the fluorescent activity and quantification of the
TaqMan® probe, which undergoes cleavage in proportion
to the amount of PCR product formed [5,6]. By recording
the amount of fluorescence emission at each cycle, it is
possible to monitor the PCR reaction during the exponen-
tial phase where the first significant increase occurs and
the amount of PCR product correlates to the initial
amount of target template.
An appropriate internal control for Q-RT-PCR should be
expressed stably across all data samples and if this is true,
measurement of genes relative to the internal control will
reflect the real gene expression. It implies that a reference
gene should have a small variance and a sufficient inten-
sity when applied as an appropriate internal control.
Moreover, most published studies have focused on the
identification of reference genes that can be used to nor-
malize expression of a gene across patient samples or tis-
sue types rather than within one specific type of tissue or
cell line [7,8]. Generally speaking, housekeeping genes,
such as ACTB (actin, β), GAPDH (glyceraldehyde-3-phos-
phate dehydrogenase), and 18S ribosomal RNA, are com-
monly employed in Q-RT-PCR analysis [9-11]. However,
several studies have also demonstrated that the gene
expression patterns of many commonly used internal con-
trols may vary as a result of tissue type, experimental con-
ditions or pathological state [12-15]. The "perfect" control
gene for all Q-RT-PCR does not exist because variability in
Q-RT-PCR data can also stem from differences in the
expression of the reference gene, for example GAPDH and
ATCB, on which the expression of all the other genes is
based [16]. Although 18S ribosomal RNA has been shown
to be a reliable control in many studies [7,8,17], it does
not undergo reverse transcription when using oligo (dT)
primers and is inappropriate for use when such primers
are used. Szabo et al. developed statistical models to assist
in identifying appropriate housekeeping genes as Q-RT-
PCR normalization controls in one or multiple types of
tissue samples [18]. However, their rigorous approach
heavily relies on an assumption that there is a multivariate
normal distribution for the microarray expression levels
and may not fit a practical situation, especially without a
large number of arrays. In addition, their models are only
applicable to the analysis of random samples, not paired
samples collected from each patient as in this study.
We aimed to address two unanswered questions associ-
ated with microarray target selections for Q-RT-PCR vali-
dation. Firstly, it is not certain which gene or genes can
serve as better internal controls for Q-RT-PCR simply
because there is no perfect internal control [15]. Secondly,
a major challenge when scoring the correlation between
microarray and Q-RT-PCR measurements remains unset-
tled because different probe level normalization methods
may result in different correlations. In this study, we pro-
pose a statistical re-sampling method to display the varia-
tion pattern or to calculate the inter-quartile range (IQR)
and the variance of gene expression levels that are associ-
ated with different probe level normalization methods.
We utilized the block bootstrap re-sampling technique to
circumvent the within-block dependence of Affymetrix
microarray data when using paired adjacent normal and
tumor samples from lung adenocarcinoma patients.
Moreover, we employed box plot results for lung adeno-
carcinoma gene expression and identified DDX5  as a
novel internal control for Q-RT-PCR. DDX5 is a highly
conserved member of the DEAD box family and is known
to be a RNA helicase that is involved in both pre-mRNA
and pre-rRNA processing [19]. Twenty-three genes, which
were differentially expressed between adjacent normal
and tumor samples, were further selected for Q-RT-PCR
analysis and were examined by microarray analysis with
several probe level quantile normalization methods using
either DDX5 or GAPDH as internal controls. No matter
which probe level quantile normalization was used forBMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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comparison,  DDX5  was a better internal control than
GAPDH for lung cancer datasets.
Results and Discussion
Identification of a novel internal control through variation 
in gene expression levels
Differentially expressed genes, identified by microarray
through global normalization, require validation of their
expression patterns through Q-RT-PCR, which generally
employees one internal control for normalization. This
distinct normalization method calls for a correct internal
control for the microarray and Q-RT-PCR data compari-
son. To prioritize the potential internal controls for Q-RT-
PCR analyses and to study the possibility of general utili-
zation of these potential internal controls, we first applied
the block bootstrapping technique to rank genes with var-
iance and IQR (Fig. 1). This method was then used to eval-
uate the gene expression patterns of the various internal
controls in a lung adenocarcinoma microarray dataset
(referred to as NHRI dataset) with the goal to provide
insights into which internal controls might be a best
choice in this study. For illustration, we first used the RMA
for probe-cell level normalization and expression-value
summary of the 66 microarrays in the NHRI dataset. Asso-
ciated with each gene, the appropriate averages of 1,000
bootstrap replicates for the 5 computed statistics pro-
duced a box plot that disclosed variation in gene expres-
sion. As a result, many potential internal controls were
revealed. To prioritize the targets, we removed those with
lower intensity signals and the multiple probe sets on
Affymetrix chip with potential cross hybridization con-
tamination between genes as determined by NetAffx™
Analysis Center [20]. The remaining 14 candidate internal
controls, which exhibited small variance expression, were
identified using the box plots and these were DDX5,
PKM2, BHLHB2, GLO1, LAPTM4A, SET, KIAA0152, CLTC,
MSN,  ABCF1,  EPHB3,  CCL5,  PTPN21  and  DDR1  (Fig.
2A). In addition, the box plots for 10 well-known internal
controls [15,21] (containing 23 probe sets) are also
shown in Figure 2A. Surprisingly, 13 out of 23 probe sets
have various levels of cross hybridization as identified by
the NetAffx™ Analysis Center (Table 1). The unique char-
acteristics of these well-known internal controls for Q-RT-
PCR are their high expression levels and there are also
huge variances.
The copy number of the individual housekeeping gene
chosen for relative quantification should be in a similar
range to that of the target gene to make comparative quan-
tification possible [22]. Further analysis indicates that we
can identify a series of internal control candidates, which
have characteristics of small variance in different microar-
ray intensity intervals (Additional file 1). These potential
internal controls are presented in different intensity
ranges in order to appropriately normalize different target
genes. Despite the fact that these potential internal con-
trols may exhibit a greater variance than DDX5 or other
internal controls listed in Figure 2A, these potential inter-
nal controls have much smaller variance than ACTB and
GAPDH (Additional file 1, right portion). This finding
Table 1: Summary of probe set characteristics of 10 well-known internal controls for Q-RT-PCR in Affymetrix HG-U133A chip
Gene symbol Probe set ID Cross-hybridization Column # in Fig. 2A
ACTB AFFX-HSAC07/X00351_M_at no 1
AFFX-HSAC07/X00351_5_at no 2
AFFX-HSAC07/X00351_3_at no 3
200801 _x at yes 4
GAPDH AFFX-HUMCAPDH/M33197_M_at no 5
AFFX-HUMGAPDH/M33197_5_at no 6
AFFX-HUMGAPDH/M33197_3_at no 7
217398_x_at yes 8
213453_x at yes 9
212581_x_at yes 10
B2M 216231_s_at yes 11
201891_s_at yes 12
HMBS 203040_s_at no 13
HPRT1 202854_at no 14
RPL13A 212790_x_at yes 15
211942_x_at yes 16
210646_x_at yes 17
200716_x_at yes 18
200715_x at yes 19
RPL32 200674_s_at no 20
SDHA 201093_x_at yes 21
UBC 211296_x_at yes 22
YWHAZ 214848_at no 23BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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further supports a view that the intensities of normalized
microarray data and the copy numbers of Q-RT-PCR
detections in gene expression patterns could be examined
in a similar range. Our approach may provide a method
to identify potential internal controls to be in a similar
range of expression as the selected target genes.
To prioritize the potential internal control for the lung
cancer microarray data, two major public accessible lung
cancer microarray datasets, which also used Affymetrix
chips, namely the Boston and the Ann Arbor datasets
[23,24], were included for data comparison. Eleven candi-
dates, after the exclusion of ABCF1,  BHLHB2  and
LAPTM4A, were available in both Boston and Ann Arbor
datasets and were included in the analysis. Figure 2B and
2C show the results of basic bootstrapping using these
two datasets of unpaired design. All 11 candidates exhib-
ited less variation than most well known internal controls,
suggesting that all 11 candidates have potential to serve as
an internal control, at least for lung cancer. To finalize the
target for further empirical validation, these potential con-
trols were sorted in the order of increasing gene expres-
sion intensities and decreasing IQR, respectively. As a
result, CLTC, DDX5 and MSN were found to exhibit suffi-
cient intensity. However, DDX5 gave the smallest varia-
tion among the three. Therefore, in this study, we chose
DDX5 for further characterization.
Considering this study was a paired design with a moder-
ate sample size, we applied the block bootstrapping tech-
nique and evaluated the gene expression patterns of
various internal controls using the NHRI dataset (as
described in Materials and Methods). A total of 39 blocks,
resulting from 27 pairs of adjacent normal and tumor
samples and 12 un-paired samples of microarrays, were
used in the block bootstrap. The re-sampling process was
repeated 1,000 times to obtained 1,000 bootstrap repli-
cates of the minimum, first quartile, median, third quar-
tile and maximum for the expression level of each gene.
The bootstrap replicates for all five statistics for DDX5
expression are roughly constants, but those for GAPDH
expression vary greatly (Fig. 3).
DDX5  exhibited relatively similar expression patterns
between adjacent normal and tumor samples as well as
across various lung cancer cell lines when compared to
GAPDH (Fig. 4). In addition to RMA, we also employed
the other two different methods, MAS5 and GC-RMA, for
the probe normalization to analyze 66 Affymetrix micro-
array chips using lung adenocarcinoma RNA samples. The
three different normalization methods displayed consist-
ent expression patterns for DDX5, suggesting that DDX5
may serve as a reliable internal control [25].
Q-RT-PCR validation and comparison with microarray
We employed Affymetrix HG-U133A chips to elucidate
the gene expression profiles for 27 pairwise primary lung
adenocarcinomas. In total, 4437 out of 22283 differential
expression transcripts between adjacent normal and
tumor parts were clustered by the Wilcoxon signed-rank
test with p-value (p < 0.01) adjusted for multiple genes in
terms of the false discovery rate [26]. By examining 24
paired lung adenocarcinoma samples with Q-RT-PCR, the
results from 23 genes were subject to statistical analysis.
Two internal controls, DDX5 and GAPDH, were used to
obtain the relative expression patterns and the results
compared. The correlation between microarray with RMA
normalization and Q-RT-PCR were analyzed by Pearson's
and Kendall's τ correlations and the summary is shown in
Table 2. Based on Pearson's correlation coefficient, the
percentage of genes with significant correlations between
the microarray and Q-RT-PCR expression was 70% (16
out of 23) using DDX5  normalization, which is much
higher than the 48% (11 out of 23) for GAPDH. If we only
focus on the significant Q-RT-PCR expressions (using
DDX5 as an internal control) based on tumor vs. adjacent
normal, the percentage of genes with similar patterns
between microarray and Q-RT-PCR expression was 91%
(21 out of 23). Similar results were also observed using
Kendall's τ correlation coefficient (Table 2). To address
whether a good internal control for Q-RT-PCR was able to
reflect the gene expression pattern in microarray, differen-
tially expressed genes identified by the Wilcoxon signed-
Flow chart for prioritization of potential internal controls Figure 1
Flow chart for prioritization of potential internal controls.BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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Bootstrap box plots of the gene expression intensity of various internal controls Figure 2
Bootstrap box plots of the gene expression intensity of various internal controls. (A) The box plot results show the 
best 14 internal control candidates, all of which exhibited consistent expression intensity in the NHRI lung adenocarcinoma 
microarray dataset for each re-sampling process. Moreover, also included are 10 well-known Q-RT-PCR internal controls con-
tained in 23 probe sets on the HG-U133A chip. These are shown as #1–23 in x-axis. The detailed probe set characteristics 
were shown in Table 1. Except ABCF1, BHLHB2 and LAPTM4A, the gene expression intensities of top 12 internal control candi-
dates, GAPDH, and ACTB from the Boston (B) and the Ann Arbor lung cancer datasets (C) were also compared. DDX5: (DEAD 
(Asp-Glu-Ala-Asp) box polypeptide 5), PKM2: (pyruvate kinase, muscle), BHLHB2: (basic helix-loop-helix domain containing, 
class B, 2), GLO1: (glyoxalase I), LAPTM4A: (lysosomal-associated protein transmembrane 4 alpha), SET: (SET translocation 
(myeloid leukemia-associated)), CLTC: (clathrin, heavy chain (Hc)), MSN: (MSN/ALK fusion; moesin/anaplastic lymphoma kinase 
fusion protein), ABCF1: (ATP-binding cassette, sub-family F (GCN20), member 1), EPHB3: (EPH receptor B3), CCL5: (chemok-
ine (C-C motif) ligand 5), PTPN21: (protein tyrosine phosphatase, non-receptor type 21), DDR1: (discoidin domain receptor 
family, member 1), 1–4: ACTB (actin, beta), 5–6: B2M (beta-2-microglobulin), 7–12: GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase), 13: HMBS (hydroxymethylbilane synthase), 14: HPRT1 (hypoxanthine phosphoribosyltransferase 1), 15–19: RPL13A 
(ribosomal protein L13a), 20: RPL32 (ribosomal protein L32), 21: SDHA (succinate dehydrogenase complex, subunit A, flavo-
protein (Fp)), 22: UBC (ubiquitin C), 23: YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, 
zeta polypeptide).BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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rank test with p values ranging from 10-2 to 10-6 were com-
pared with the Q-RT-PCR results. Again, a percentage
around 80% of significant correlation was found when
DDX5 was used as an internal control.
The expression pattern comparisons of DDX5 in other 
microarray datasets
To explore the possibility that DDX5 can be generally uti-
lized as an internal control, we further analyzed DDX5
expression patterns using a new Affymetrix based NCI60
dataset [27] from Genomics Institute of the Novartis
Research Foundation (GNF). The expression patterns of
DDX5 were investigated in 8 different types of cancer cell
lines (NCI60) and several additional cell lines with a total
of 84 cell lines and DDX5 exhibited much smaller varia-
tion than GAPDH for all cell types (Fig. 5A). Moreover, the
expression patterns of DDX5, CLTC and MSN (Fig. 5B)
were further compared with ACTB  and GAPDH  in the
lung cancer cell lines found in NCI60. All three candidates
showed less variance than both well-known internal con-
trols. Similar patterns were also observed in our NHRI
dataset (Fig. 2A). Additional cDNA microarray datasets
were also downloaded from Stanford Microarray Data-
base [28], including lung cancers [29], hepatocellular car-
cinomas (HCC) [30] and the HeLa cell cycle dataset [31],
which reported cell cycle related genes by synchronizing
HeLa cells at different phases of cell cycle [32] (Fig. 5C).
Based on these comparisons, we conclude that DDX5 is
evidently a novel internal control with a relatively con-
stant expression pattern in lung adenocarcinoma. In addi-
tion, using limited microarray datasets analyzed in this
paper, the variation in DDX5 levels was also relatively
small in other cancer cell lines, raising the possibility that
DDX5 could serve as a novel internal control.
Conclusion
In summary, we adapted block bootstrap for using with a
paired design to circumvent the within-pair dependence.
This proposed re-sampling strategy together with the use
of a box plot provides a useful distribution-free statistical
procedure for exploratory data analysis. This systematic
analysis procedure focused on identifying genes with min-
imal variation in their microarray data, which facilitates
the essential internal control selection steps prior to Q-RT-
PCR analysis. Finally, systematic microarray and Q-RT-
PCR analyses reveal that the proposed re-sampling tech-
nique of block bootstrap suits paired design experiments
and adequately detects genes with minimal variation in a
microarray dataset.
Methods
Sample preparation
A total of 66 samples were used for microarray analysis,
including paired adjacent normal-tumor samples from 27
patients underwent surgery for lung cancer at the Taipei
Bootstrap replicates of the descriptive statistics related to  the variation in gene expression Figure 3
Bootstrap replicates of the descriptive statistics 
related to the variation in gene expression. In total, 27 
pairs of adjacent normal and tumor samples with 12 un-
paired samples were used in this analysis. A total of 39 blocks 
of microarray samples were used for the block bootstrap. 
The re-sampling process was repeated 1,000 times to obtain 
1,000 bootstrap replicates of the minimum (green color), 
first quartile (red color), median (black color), third quartile 
(blue color) and maximum (cyan color) expression levels for 
each gene. Each result was ranked by the order of medians. 
The bootstrap replicates of all five statistics for DDX5 
expression remain roughly constants, but those for GAPDH 
expression vary greatly.BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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Gene expression patterns of DDX5 and GAPDH from 66 Affymetrix microarray chips using three different probe level quantile  normalizations Figure 4
Gene expression patterns of DDX5 and GAPDH from 66 Affymetrix microarray chips using three different 
probe level quantile normalizations. The gene expression patterns of two internal controls, DDX5 (A) and GAPDH (B: 
212581_x_at and C: M33197_3_at) from Affymetrix chips by MAS5 (marked by diamonds), RMA (marked by squares) and GC-
RMA (marked by triangles) probe level quantile normalizations. Normalization was performed per chip and per gene using 
GeneSpring® 7.3 software. The expression levels of these two internal controls were related to the median of the intensities 
on the 66 chips. The DDX5 expression patterns in each chip did not significantly alter compared to greater variation in GAPDH.BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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Veterans General Hospital, two tissue mixtures from the
Taichung Veterans General Hospital (one was adjacent
normal lung mixtures and the other was lung adenocarci-
noma mixtures), two commercial human normal lung tis-
sues (Clontech (Catalog No. 636524) and Stratagene
(Catalog No. 735020)), one immortalized, nontumori-
genic human bronchial epithelial cell line (NL-20 (ATCC®
No. CRL-2503™)) and 7 lung cancer cell lines (A-549
(ATCC® No. CCL-185™), NCI-H1299 (ATCC® No. CRL-
5803™), NCI-H661 (ATCC® No. HTB-183™), CL1-0 [33],
CL1-1 [33], CL1–5 [33], and CL1–5-F4 [34]).
RNA extraction and reverse transcription
We used the total RNA samples for Q-RT-PCR analyses.
RNA preparation and analysis were performed according
to the previous study [11]. Briefly, the quality of the total
RNA for microarray analysis was determined using Spectra
Max Plus (Molecular Devices) and had an OD260/OD280
ratio ranging from 1.9 to 2.1. RNA was subjected to
reverse transcription with random hexamer primers. To
hydrolyze contaminating DNA in the RNA preparations,
RNA was incubated with amplification-grade DNase I
(Life Technologies, Gaithersburg, MD). After incubating
the reaction mixture, the reaction was stopped by heating
at 65°C. After DNase treatment, the RNA was subjected to
reverse transcription reaction by the ThermoScript™ RT-
PCR system (Life Technologies) and cDNAs were then
used in the Q-RT-PCR.
Q-RT-PCR
Q-RT-PCR was used to measure the mRNA expression lev-
els of various differentially expressed genes between adja-
cent normal and lung tumors by using 384-well plates
(ABI PRISM 7900 HT Sequence Detection System). The
cDNAs were served as templates (diluted 200×) for Q-RT-
PCR by using TaqMan® Universal PCR Master Mix kit
(Applied Biosystems, Foster City, CA). Each 10 μl of quan-
titative PCR reaction mixture contained 5 μl of 2× Taq-
Man® Universal Master Mixture (Applied Biosystems), 4 μl
of 200× diluted cDNA product mixture, and 1 μl of PCR
forward and reverse primers and probe. To standardize
the quantification of the selected target genes, DDX5 and
GAPDH served as internal controls and were quantified
on the same plate as the target genes. The cycle threshold
(CT) value of DDX5 or GAPDH was used to normalize the
target gene expression values, referred to as the ΔCT,
which was used to adjust differences among samples.
Approximately 50 genes were selected as the start of this
study. These genes were subjected to Q-RT-PCR analysis
under 200× diluted cDNA conditions due to insufficient
cDNA for large-scale screening. The reaction products by
agarose gel electrophoresis showed that many of the
amplifications contained no detectable PCR product. If
the Q-RT-PCR reactions failed in 50% of the assays, the
data were excluded from further statistical analysis. In
addition, several gene products exhibited multiple bands
when examined on the agarose gels. Even though we used
the TaqMan system, we were not comfortable with such
data and these were also discarded. The Assays-on-
Demand IDs (Applied Biosystems) for the 25 genes are
shown in Table 3.
Microarray experiments, normalization and Wilcoxon 
signed-rank test
Protocols, reagents for hybridization, washing and stain-
ing followed previous methods [35] and the Affymetrix's
instructions [36]. Labeled cDNA was hybridized to the
Affymetrix GeneChip Test 3 Array to verify quality prior to
hybridize to the Affymetrix Human Genome U133A
Array. The data discussed in this publication have been
deposited in NCBIs Gene Expression Omnibus (GEO)
[37] and are accessible through GEO Series accession
number GSE7670. The images were transformed into text
files as intensity information using the MAS5.0 (Microar-
ray Suite software 5.0) developed by Affymetrix [38,39].
We used three array processing methods to produce and
normalize the Affymetrix expression signals for the tran-
scripts based on corresponding probe pairs of oligonucle-
otides. MAS5.0 as provided by Affymetrix was used to
carry out the probe-pairs adjustment. Both MAS5.0 and
RMA [40], Robust Multichip Average via quantile adjust-
Table 2: Summary of the correlations between microarray and 
Q-RT-PCR analyzed by Pearson's and Kendall's τ correlations.
Gene Pearson's Correlation Kendall's τ Correlation
DDX5 GAPDH DDX5 GAPDH
ASK 0.13 -0.16 0.14 -0.19
BUB1B 0.53 0.47 0.39 0.33
CDCA8 0.68* 0.49 0.52* 0.36
CENTD2 0.65** 0.16 0.50** 0.05
CXCL5 0.62** 0.60** 0.39** 0.34*
CYP27A1 0.30 0.53** 0.19 0.41**
FLJ10540 0.70** 0.35 0.50** 0.16
FLJ20530 0.54** -0.14 0.40** -0.08
FLJ20605 0.03 0.25 0.01 0.18
FY 0.47* 0.52* 0.30* 0.34*
FZD4 0.45* 0.42 0.28 0.25
GARP 0.55* 0.53* 0.24 0.26
MMP9 0.70** 0.64** 0.54** 0.49**
MSR1 0.79** 0.79** 0.50** 0.57**
PA26 0.56** 0.68** 0.35* 0.49**
S100A2 0.67** 0.57** 0.42** 0.38**
SERPINA3 0.70** 0.49 0.49* 0.41*
SOX4 0.11 0.14 -0.06 -0.03
SRD5A1 0.69** 0.61** 0.50** 0.37*
T1A-2 0.31 0.19 0.22 0.13
TEK 0.41 0.47* 0.24 0.32*
TOPK 0.58** 0.28 0.39* 0.16
TROAP 0.60** 0.46* 0.40** 0.30*
*: P < 0.05, **: P < 0.01.BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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Box plots of DDX5 relative expression patterns exhibit small variation across various microarray datasets Figure 5
Box plots of DDX5 relative expression patterns exhibit small variation across various microarray datasets. The 
gene expression patterns of DDX5 were obtained from other microarray databases. These datasets were from 84 cancer cell 
lines (NCI60), which were classified into 8 different cancer cell types and other cell lines (A). GAPDH #5: M33197_3_at; GAPDH 
#10: 212581_x_at. The box plot results indicated that DDX5 exhibited only small variation across the various NCI60 cell types. 
For the lung cancer cell lines, DDX5, CLTC and MSN all gave lower variances than ACTB and GAPDH (B). Both ACTB (#1–4) and 
GAPDH (#5–10) are contained in 10 probe sets on the HG-U133A chip and are shown as #1–10 on x-axis and in Table 1. The 
variation of DDX5 was also smaller for the HeLa cell cycle dataset, lung cancer dataset and HCC dataset from the Stanford 
Microarray Database (C). BR: breast cancer, CO: colon cancer, GL: glioblastoma, KI: Kidney, LE: leukemia, LU: lung cancer, 
ME: melanoma and OV: ovarian cancer.BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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ment, are commonly used. Another algorithm GC-RMA
[41] is similar to RMA, but pools the probes with compa-
rable numbers of G-C bonds to achieve a stable mismatch
adjustment. Based on paired adjacent normal and tumor
samples of 27 patients, we used the Wilcoxon signed-rank
test [42] to identify differentially expressed genes. In con-
trast to Student's t-test inappropriately used in some stud-
ies [43], the signed-rank test is distribution-free and
adjusts for the paired design.
Block bootstrapping
To assess the variation in the microarray expression level
for a specified gene in an experiment of moderate sample
size and possibly including paired samples, we designed a
block bootstrapping procedure to analyze the microarray
data from 66 lung samples, containing 27 pairs of patient
adjacent normal-tumor samples and 12 un-paired sam-
ples. Bootstrapping is a breakthrough statistical approach
using a computationally intensive re-sampling technique
and it allows complex problems to be solved in which the
accuracy of a devised statistical procedure can not be ana-
lytically evaluated [44,45]. Block bootstrapping was orig-
inally named for re-sampling methods in dependent
cases, especially time series data [46]. The basic bootstrap
generates artificial samples that allow the making of an
inference of interest through re-sampling the original data
with replacement in which all observations are assumed
to be mutually independent and from the same distribu-
tion. To guarantee the structure of independence in boot-
strap re-sampling, we employed the concept of blocking
for the paired data by treating each individual patient,
mixture tissue or cell line as a block. By selecting an obser-
vation within the block with equal probability when com-
bined with all the other un-paired samples, we obtained
an independently re-sampled dataset. We then created a
bootstrap sample by randomly sampling the blocks in the
dataset, and computed the bootstrap replicates of the rel-
evant summary statistics of the expression levels. Repeat-
ing this bootstrap re-sampling scheme sufficient times,
such as 1,000, we then used the averages of these boot-
strap replicates to reveal the variation in expression sum-
maries corresponding to a specific gene across the
microarrays. Appropriate internal controls can be selected
by ranking the variations in gene expression.
Correlations of microarray and Q-RT-PCR data
To explicate the correlation between microarray and Q-
RT-PCR in this study of paired design, we calculated the
differences between the log-scaled measurements of the
Q-RT-PCR and microarraydata from the tumor and adja-
cent normal tissues of 24 patients. The other 3 paired sam-
ples did not have sufficient materials for further Q-RT-
PCR analysis. Pearson's and Kendall's τ correlation coeffi-
cients were then tested at a significant level of 0.05. Sum-
Table 3: Summary table of Assays-on-Demand ID of 23 genes and 2 internal controls for Q-RT-PCR.
Genes Description Assays-on-Demand ID
ASK activator of S phase kinase Hs00272696_m1
BDB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) Hs00176169_m1
CDCA8 cell division cycle associated 8 Hs00216479_m1
CKNTD2 centaurin, delta 2 Hs00362929_m1
CXCL5 chemokine (C-X-C motif) ligand 5 Hs00171085_m1
CYP27A1 cytochrome P450, family 27, subfamily A, polypeptide 1 Hs00168003_m1
FLJ10540 chromosome 10 open reading frame 3 Hs00216688_m1
FLJ20530 hypothetical protein FLJ20530 Hs00215334_m1
FLJ20605 hypothetical protein FLJ20605 Hs00215486_m1
FY Duffy blood group Hs00266671_s1
FZD4 frizzled homolog 4(Drosophila) Hs00201853_m1
GARP glycoprotein A repetitions predominant Hs00194136_m1
MMP9 matrix metalloproteinase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) Hs00234579_m1
MSR1 macrophage scavenger receptor 1 Hs00234007_m1
PA26 sestrin 1 Hs00205427_m1
S100A2 S100 calcium binding protein A2 Hs00195582_m1
SERPINA3 serine (or cysteine) proteinase inhibitpr, clade A (alpha-1 antiproteinase, antitrypsin), member 3 Hs00153674_m1
SOX4 SRY(sex determining region Y)-box 4 Hs00268388_s1
SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase Hs00602694_mH
alpha 1)
T1A-2 lung type-I cell membrane-associated glycoprotein Hs00366764_m1
TEK TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) Hs00176096_m1
TOPK T-LAK cell-originated protein kinase Hs00902988_m1
TROAP trophinin associated protein (tastin) Hs00193896_m1
DDX5 DEAD (Asp-(Glu-Ala-Asp) box polypeptide 5 Hs00189323_m1
GAPDH glyceraldehyde-3-phosphate dehydrogenase Hs99999905_m1BMC Genomics 2007, 8:140 http://www.biomedcentral.com/1471-2164/8/140
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marization of the expression levels and normalization for
microarray data were conducted using GeneSpring® 7.3
(Silicon Genetics, Redwood City, CA). The computer pro-
grams for the block bootstrapping method and correla-
tion using R 2.1.1 [47] are presented in the Additional File
2.
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